0001438133-20-000130.txt : 20200812
0001438133-20-000130.hdr.sgml : 20200812
20200812184344
ACCESSION NUMBER: 0001438133-20-000130
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200810
FILED AS OF DATE: 20200812
DATE AS OF CHANGE: 20200812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BLICKENSTAFF KIM D
CENTRAL INDEX KEY: 0001238913
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36189
FILM NUMBER: 201096550
MAIL ADDRESS:
STREET 1: C/O MEDIVATION, INC.
STREET 2: 201 SPEAR STREET, 3RD FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC
CENTRAL INDEX KEY: 0001438133
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204327508
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-366-6900
MAIL ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
4
1
wf-form4_159727221114150.xml
FORM 4
X0306
4
2020-08-10
0
0001438133
TANDEM DIABETES CARE INC
TNDM
0001238913
BLICKENSTAFF KIM D
C/O TANDEM DIABETES CARE, INC.
11075 ROSELLE STREET
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2020-08-10
4
M
0
8882
51.50
A
882518
I
See Footnote
Common Stock
2020-08-10
4
S
0
4248
103.3389
D
878270
I
See Footnote
Common Stock
2020-08-10
4
S
0
4134
104.3209
D
874136
I
See Footnote
Common Stock
2020-08-10
4
S
0
500
104.848
D
873636
I
See Footnote
Common Stock
2020-08-10
4
M
0
2686
51.50
A
876322
I
See Footnote
Stock Option
51.5
2020-08-10
4
M
0
11568
0
D
Common Stock
11568.0
159210
D
Represents shares of common stock received upon exercise of a stock option award.
The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $102.72 to $103.69. The Reporting Person undertakes to provide the Securitiesand Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $103.78 to $104.72. The Reporting Person undertakes to provide the Securitiesand Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $104.79 to $104.87. The Reporting Person undertakes to provide the Securitiesand Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The option vested as to twenty-five percent (25%) of the underlying shares on 02/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter.
The expiration date for these options is 10 years from the date of grant.
s/ David B. Berger, Attorney-in-Fact for Kim D. Blickenstaff
2020-08-12